Onkologie. 2017:11(4):196-199 | DOI: 10.36290/xon.2017.037

Possibilities of interventions of selected gastrointestinal disorders accompanying malignant diseases

Petra Holečková
Ústav radiační onkologie Nemocnice Na Bulovce a 1. LF UK Praha

Gastrointestinal tract is a system which includes oesophagus, stomach, small and large intestine, pancreas and hepatobiliarytract. Many gastrointestinal disordes accompay malignant diseases. Many of these disorders are caused directly by malignantdiseases many of them occure like toxicity of treatment – surgery, radiotherapy, cytostatic therapy, targeted biology treatmentor immunotherapy. Intervention must be selected according to type of disorder, its severity and status of a patient.

Keywords: gastrointestinal tract, gastrointestinal disorders, oncology treatment

Published: October 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holečková P. Possibilities of interventions of selected gastrointestinal disorders accompanying malignant diseases. Onkologie. 2017;11(4):196-199. doi: 10.36290/xon.2017.037.
Download citation

References

  1. Lukáš M, Novotný A, Adamec S. Syndromy v klinické gastroenterologii. Lékařské listy [online]. 1999, 1999(36), - [cit. 2017-01-27]. Dostupné z: http://zdravi.euro.cz/clanek/priloha-lekarske-listy/syndromy-v-klinicke-gastroenterologii-121383.
  2. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), Int J Radiat Oncol Biol Phys. 1995; 31(5): 1341-1346. Go to original source... Go to PubMed...
  3. Hindy P, Hong J, Lam-Tsai Y, et al. A Comprehensive Review of Esophageal Stents, Gastroenterol Hepatol, 2012; 8(8): 526-534.
  4. Hoskovec D. Léčba karcinomu žaludku a gastroezofageální junkce. Postgraduální medicína [online]. 2012, -(4/2012), - [cit. 2017-01-27]. Dostupné z: http://zdravi.euro.cz/clanek/postgradualni-medicina/lecba-karcinomu-zaludku-a-gastroezofagealni-junkce-464248.
  5. Kasper H. Výživa v medicíně a dietetika. Praha: Grada, 2015: 4533-4536.
  6. Becker HD. Chirurgická onkologie. Praha: Grada, 2005, 880 s.
  7. Zadák Z. Výživa v intenzivní péči. 2., rozš. a aktualiz. vyd. Praha: Grada, 2008: 542 s.
  8. Bureš J, Kopáčová M, Rajchrt S. Syndrom krátkého střeva u dospělých. Postgraduální medicína [online]. 2007, 8/2007, - [cit. 2017-01-25]. Dostupné z: http://zdravi.euro.cz/clanek/postgradualni-medicina/syndrom-kratkeho-streva-u-dospelych-323595.
  9. Andreyev HJN, Davidson SE, Gillespie C, et al. Gut. BMJ Journals [online]. 2011, Dostupné z http://gut.bmj.com/content/early/2011/11/04/gutjnl-2011-300563.full.pdf+html.
  10. Vokurka S. Postižení dutiny ústní a trávicího traktu onkologických pacientů. Praha: Current Media, 2016: 228 s.
  11. Ikehara O. Vincristine-induced paralytic ileus: role of fiberoptic colonoscopy and prostaglandin F2 alpha. Am J Gastroenterol. 1992; 87(2): 207-210.
  12. Postow M, Wolchow J. Toxicities associated with checkpoint inhibitor immunotherapy. UpToDate [online]. 2017, Jan 2017 [cit. 2017-02-01]. Dostupné z: http://www.uptodate.com/contents/toxicities-associated-with-checkpoint-inhibitor-immunotherapy#H645932.
  13. Šachlová M, Tomíška M, Sláma O. Nutriční péče u pacientů v onkologické paliativní péči Stanovisko pracovní skupiny pro výživu České společnosti paliativní medicíny ČLS JEP, Praha, Ambit Media, 1. vydání, Praha 2012.
  14. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition [online]. V tisku, 2016, 1-38 [cit.2017-01-31]. Dostupné z: http://www.espen.info/wp/wordpress/wp-content/uploads/2016/11/ESPEN-cancer-guidelines-2016-final-published.pdf.
  15. Preedy VR. Diet and nutrition in palliative care. Boca Raton, FL: CRC Press, c2011. Go to original source...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.